Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04595994
Title Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
Acronym SeliSarc
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Grupo Espanol de Investigacion en Sarcomas
Age Groups: adult | senior
Covered Countries ESP

No variant requirements are available.